JPH05337192A - Semiconductor curing agent - Google Patents

Semiconductor curing agent

Info

Publication number
JPH05337192A
JPH05337192A JP3885193A JP3885193A JPH05337192A JP H05337192 A JPH05337192 A JP H05337192A JP 3885193 A JP3885193 A JP 3885193A JP 3885193 A JP3885193 A JP 3885193A JP H05337192 A JPH05337192 A JP H05337192A
Authority
JP
Japan
Prior art keywords
semiconductor
type semiconductor
thin film
type
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3885193A
Other languages
Japanese (ja)
Other versions
JP2572520B2 (en
Inventor
Saburo Ishiguro
三郎 石黒
Tatsuo Inoue
達夫 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Furukawa Co Ltd
Original Assignee
Furukawa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Furukawa Co Ltd filed Critical Furukawa Co Ltd
Priority to JP5038851A priority Critical patent/JP2572520B2/en
Publication of JPH05337192A publication Critical patent/JPH05337192A/en
Application granted granted Critical
Publication of JP2572520B2 publication Critical patent/JP2572520B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To improve curing effect of a semiconductor curing agent and to make it possible to cure easily a musclar ache, a stiff shoulder etc. CONSTITUTION:A semiconductor curing agent is constituted of a p-type semiconductor which can be brought into contact with the skin surface or a human body. A thin film-type p-type semicondactor is formed on the surface of a molding such as a ceramic molding and it adheres to the skin with a plaster. A powdery p-type semiconductor is colored by adding a pigment such as titanium oxide and iron oxide to make it so as not to attract attention and it is convenient to use it if it is mixed with a cream, a pack or a hair cultivating agent.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、筋肉痛、肩こり等の治
療、及び皺とり、育毛などに使用される半導体治療剤に
関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a semiconductor therapeutic agent used for treating muscle soreness, stiff shoulders, wrinkles, hair growth and the like.

【0002】[0002]

【従来の技術】筋肉痛、肩こり等の治療に、ゲルマニウ
ム、シリコン等の半導体の結晶や金属、セラミックス等
の成形体に半導体の薄膜をコーティングしたものをプラ
スター等で皮膚に固定する半導体治療器が使用されてい
る。
2. Description of the Related Art For the treatment of muscle soreness, stiff shoulders, etc., a semiconductor treatment device for fixing a semiconductor crystal such as germanium or silicon, a molded body of metal, ceramics or the like with a thin film of semiconductor to a skin by plaster or the like is available. It is used.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、このよ
うな半導体治療器では、p形半導体とn形半導体の効果
の差が看過され、半導体の形については全く配慮されて
いなかったため、その効果にばらつきがあった。本発明
は、p形半導体とn形半導体との生理作用の差に着目
し、半導体治療器におけるかかる問題を解決するもので
あって、治療効果が良く、筋肉痛、肩こり等の治療に加
え、皺とり、育毛などにも有効で、簡単に目立たない状
態で使用できる半導体治療剤を提供することを目的とす
る。
However, in such a semiconductor therapeutic device, the difference in effect between the p-type semiconductor and the n-type semiconductor was overlooked, and the shape of the semiconductor was not taken into consideration at all. was there. The present invention focuses on a difference in physiological action between a p-type semiconductor and an n-type semiconductor, and solves such a problem in a semiconductor therapeutic device. The therapeutic effect is good, and in addition to treatment of muscle pain, stiff shoulder, etc., It is an object of the present invention to provide a semiconductor therapeutic agent that is effective for wrinkle removal, hair growth, etc. and can be used in an easily inconspicuous state.

【0004】[0004]

【課題を解決するための手段】一般に、半導体を皮膚に
接触させるとサーモグラフィやレーザスペックル血流計
を用いた測定により血流が増加することが認められる。
血流が増加すれば、毛細血管に滞留していた痛みの原因
物質や疲労物質が除去されるので、筋肉痛や凝りが解消
するものと考えられる。半導体にはp形半導体とn形半
導体とがあり、シリコンを例にとると高純度シリコンに
III価元素の硼素やアルミニウムなどを微量添加すると
電子不足のp形半導体となり、V価元素の燐やアンチモ
ンなど微量添加すると電子過剰のn形半導体となる。p
形とn形の粉末状の半導体を皮膚に塗布して筋肉痛など
の治療試験を行ったところ、p形半導体に顕著な効果が
認められた。n形半導体は、塗布する部位によっては効
く場合もあるが、逆に痛みを生ずる場合もあり治療に使
用するには不適当である。これに対し、p形半導体は、
全体の80%以上に効果が認められ、痛むという副作用
は皆無であった。しかも、粉末状のp形半導体は、従来
の半導体治療器では困難であった皺とりや育毛にも利用
できることが判明した。
It is generally recognized that when a semiconductor is brought into contact with the skin, the blood flow is increased by thermography or measurement using a laser speckle blood flow meter.
It is considered that if the blood flow is increased, the pain-causing substance and the fatigue substance accumulated in the capillaries are removed, so that muscle pain and stiffness are eliminated. Semiconductors include p-type semiconductors and n-type semiconductors. Taking silicon as an example, high-purity silicon is obtained.
Addition of a trace amount of III-valent element such as boron or aluminum results in an electron-deficient p-type semiconductor, and addition of a trace amount of V-valent element such as phosphorus or antimony results in an electron-excessive n-type semiconductor. p
When a powdery semiconductor of n-type and n-type was applied to the skin and a therapeutic test for muscle pain and the like was conducted, a remarkable effect was recognized for the p-type semiconductor. The n-type semiconductor may be effective depending on the site to which it is applied, but it may cause pain on the contrary, and is not suitable for therapeutic use. On the other hand, the p-type semiconductor is
The effect was observed in 80% or more of the whole, and there was no side effect of pain. Moreover, it has been found that the powdery p-type semiconductor can be used for wrinkle removal and hair growth, which have been difficult with conventional semiconductor therapeutic devices.

【0005】本発明は、上記知見に基づいてなされたも
のであって、半導体治療剤を人体の皮膚表面に接触可能
なp形半導体で構成することにより前記課題を解決して
いる。p形半導体としては、結晶、薄膜、粉末等が使用
できるが、結晶は材料及び成形のコストが高く実用的に
不向きである。薄膜としては、シリコン半導体薄膜、ゲ
ルマニウム半導体薄膜、ガリウム燐半導体薄膜、硫化亜
鉛半導体薄膜等が使用される。薄膜は、セラミックス、
プラスチック、ガラス、又は金属の成形体表面に形成さ
れ、p形半導体としての効果の他に誘電効果を生じる。
薄膜を成形体表面に形成する場合、成形体の形状として
は、円錐状、半球状、凸状、円盤状、リング状、クレー
タ状のものが用いられ、直径は1〜7mm、厚さは0.5
〜3mmの間で、貼付部位などりより適宜選択する。特に
好ましい形状は、円錐状、又は凸状で直径5〜7mm、厚
さ1.5〜2.5mmである。
The present invention has been made on the basis of the above findings, and solves the above-mentioned problems by forming a semiconductor therapeutic agent with a p-type semiconductor capable of contacting the skin surface of the human body. As the p-type semiconductor, crystals, thin films, powders and the like can be used, but crystals are not suitable for practical use because of high material and molding costs. As the thin film, a silicon semiconductor thin film, a germanium semiconductor thin film, a gallium phosphide semiconductor thin film, a zinc sulfide semiconductor thin film, or the like is used. The thin film is ceramics,
It is formed on the surface of a molded body of plastic, glass, or metal, and produces a dielectric effect in addition to the effect as a p-type semiconductor.
When the thin film is formed on the surface of the molded body, the shape of the molded body is conical, hemispherical, convex, disk-shaped, ring-shaped, or crater-shaped, and has a diameter of 1 to 7 mm and a thickness of 0. .5
Select appropriately within 3 mm depending on the attachment site. A particularly preferable shape is a conical or convex shape having a diameter of 5 to 7 mm and a thickness of 1.5 to 2.5 mm.

【0006】成形体の材質としては、成形性、耐久性、
半導体薄膜の付着性からセラミックスがよく用いられ
る。セラミックス表面に形成すると遠赤外線効果も相乗
的に加わる。セラミックスとしては、アルミナ、マグネ
シア、酸化珪素、酸化チタン、酸化ジルコン、酸化鉄、
酸化マンガン、酸化錫、酸化アンチモン、酸化銅、酸化
コバルト、酸化ニッケル、窒化珪素、炭化珪素の単体又
は混合物が好ましい。しかし、簡易に成形できるプラス
チック、ガラス、金属等の成形体を用いてもよい。成形
体表面への薄膜の形成は、蒸着、スパッタリング、CV
D等で行う。このようにしてp形半導体の薄膜で被覆さ
れた成形体を、プラスターやバンドにより人体のツボや
圧痛点に接触させ治療する。
[0006] As the material of the molded body, moldability, durability,
Ceramics are often used because of the adhesiveness of the semiconductor thin film. When formed on the surface of ceramics, the far infrared effect is also synergistically added. Ceramics include alumina, magnesia, silicon oxide, titanium oxide, zircon oxide, iron oxide,
A single substance or a mixture of manganese oxide, tin oxide, antimony oxide, copper oxide, cobalt oxide, nickel oxide, silicon nitride and silicon carbide is preferable. However, a molded body of plastic, glass, metal or the like that can be easily molded may be used. The thin film is formed on the surface of the compact by vapor deposition, sputtering, CV.
Perform with D etc. Thus, the molded body coated with the thin film of the p-type semiconductor is brought into contact with acupoints and tender points of the human body by plasters and bands for treatment.

【0007】粉末状のp形半導体としては、シリコン半
導体粉末、ゲルマニウム半導体粉末、ガリウム燐半導体
粉末、硫化亜鉛半導体粉末、またはその混合物を使用す
ることが好ましい。粉末状のp形半導体には、酸化チタ
ンや酸化鉄等の顔料を加えて調色し、目立たないように
すると共に遠赤外線効果を加えることができる。また、
クリーム、パック、又は育毛剤と混合しておけば、簡単
に使用できる。粉末状のp形半導体は、皮膚に貼着可能
な布、プラスチック、セラミックス等の媒体に付着させ
て使用してもよい。
As the powdery p-type semiconductor, it is preferable to use silicon semiconductor powder, germanium semiconductor powder, gallium phosphide semiconductor powder, zinc sulfide semiconductor powder, or a mixture thereof. To the powdery p-type semiconductor, a pigment such as titanium oxide or iron oxide may be added to adjust the color to make it inconspicuous, and a far infrared effect can be added. Also,
It is easy to use if mixed with a cream, pack or hair restorer. The powdery p-type semiconductor may be used by adhering it to a medium such as cloth, plastic, or ceramics that can be attached to the skin.

【0008】[0008]

【作用】通常、人間の表皮の表側は負に裏側は正に分極
していて、数十ミリボルトの電位差があり、これが大き
くなると痛みの原因となる。鍼治療の場合は、鍼を皮下
まで刺入すると皮膚の表面と裏面が電気的に短絡するた
め、異常電位が解消して痛みが無くなるといわれる。p
形半導体を皮膚の異常電位を起こしている箇所に接触さ
せると、負の電気(電子)を引きつけ、表面の異常電位
が解消される。表面の異常電位が解消されると、表皮を
間に誘電関係にある裏電位も正常に戻り、異常電位に伴
う筋肉痛も解消される。負の電気を吸収したp形半導体
は、時間を経て被服等に放電して元に戻る。なお、n形
半導体は余剰電子を持っているので、逆に異常電位を促
進する可能性があり、効果が不安定なだけでなく痛む場
合もでてくる。
Function: Normally, the front side of the human epidermis is negatively polarized and the back side is positively polarized, and there is a potential difference of several tens of millivolts, and when it becomes large, it causes pain. In the case of acupuncture, it is said that when an acupuncture needle is inserted under the skin, the front surface and the back surface of the skin are electrically short-circuited, so that the abnormal potential disappears and the pain disappears. p
When the shaped semiconductor is brought into contact with a part of the skin where an abnormal potential is generated, negative electric (electrons) are attracted and the abnormal potential on the surface is eliminated. When the abnormal potential on the surface is eliminated, the back potential, which is in a dielectric relationship between the epidermis, returns to normal, and the muscle pain associated with the abnormal potential is also eliminated. The p-type semiconductor that has absorbed the negative electricity discharges to the clothing or the like over time and returns to the original state. Since the n-type semiconductor has surplus electrons, it may promote an abnormal potential on the contrary, which may cause not only an unstable effect but also a pain.

【0009】また、p形半導体は皮膚内部の血流を増加
し活性化させる。例えば、レーザースペックル血流計で
痛みのない場所と痛みのある場所の血流ゆらぎを測定す
ると、痛みのない場所では血流ゆらぎは1/fの分布を
しているが、痛みのある場所の血流ゆらぎは1/fから
大きくシフトしている。しかし、痛みのある場所のツボ
にp形半導体で被覆した成形体を貼付すると、血流ゆら
ぎは1/fに近づき、血流が正常化することが認められ
る。従来パック剤やスキンクリームには保湿性のジアル
シルグリセロールやビタミンC、E誘導体などが含まれ
ているが、これらの成分に皮膚内部の血流増加、活性化
作用があるp形半導体を加えると、皺とりや育毛にも著
しい効果を生ずる。
Further, the p-type semiconductor increases and activates the blood flow inside the skin. For example, when measuring blood flow fluctuations in a painless place and a painful place with a laser speckle blood flow meter, the blood flow fluctuation has a distribution of 1 / f in the painless place, but the painful place The blood flow fluctuations of 1 are significantly shifted from 1 / f. However, when a molded body coated with a p-type semiconductor is attached to the acupuncture point at a painful place, the blood flow fluctuation approaches 1 / f, and it is recognized that the blood flow is normalized. Traditionally, packs and skin creams contain moisturizing dialsyl glycerol, vitamin C, E derivatives, etc., but if p-type semiconductor that increases blood flow inside skin and activates is added to these ingredients , Has a remarkable effect on wrinkle removal and hair growth.

【0010】粉末状のp形半導体の色は皮膚の色との差
が顕著であるため、皮膚に塗布すると見苦しく、使用の
際の心理的障害となるが、酸化チタンや赤色酸化鉄等の
無害な顔料を加えて調色したものは、色による違和感を
減少させる。
Since the color of powdery p-type semiconductor is significantly different from the color of skin, it is unsightly when applied to the skin and causes a psychological obstacle during use, but harmless such as titanium oxide and red iron oxide. Color tones with different pigments reduce discomfort due to color.

【0011】[0011]

【実施例】【Example】

(実施例1)硼素180ppm 添加シリコン粉末4gを資
生堂製エリクシール・トリートメント・マスク10gで
良く練り、腕の上がらない重症の肩凝り患者5名の肩
井、巨骨、曲垣、天宗、中府、雲門の各経穴に塗布し
た。塗布は毎朝と入浴した日は入浴後に行った。5日後
全快3名、80%回復1名、やや改善1名の結果が得ら
れ、効果率は80%であった。比較のため、燐400pp
m 添加シリコン粉末4gを資生堂製エリクシール・トリ
ートメント・マスク10gで良く練り、重症の肩凝り患
者3名に同条件で治験を行ったところ、改善1名、全く
改善せず1名、違和感1名であった。
(Example 1) 4 g of silicon powder added with 180 ppm of boron was well kneaded with 10 g of Elixir treatment mask manufactured by Shiseido, and 5 shoulder patients with severe stiff shoulders who did not lift their arms, shoulders, big bones, Magaki, Tenmune, Chufu , And was applied to each acupuncture point of Unmon. The application was performed every morning and on the day of bathing after bathing. After 5 days, the results were 3 for complete recovery, 1 for 80% recovery, and 1 for slightly improved, and the effect rate was 80%. For comparison, phosphorus 400pp
4g of m-added silicon powder was thoroughly kneaded with 10g of Shiseido's Elixir treatment mask, and clinical trials were carried out on 3 patients with severe stiff shoulders under the same conditions. 1 improvement, 1 no improvement, 1 discomfort there were.

【0012】(実施例2)アルミニウム0.2%添加ゲ
ルマニウム粉末5gを花王製ソフィーナモイスチュアパ
ックN20gで良く練り、中等症腰痛患者4名、重症腰
痛患者2名の承山、腎兪、志室、大腸兪、関元兪に塗布
した。塗布は毎朝と入浴後に行った。7日後中等症患者
全快3名、改善せず1名、重症患者全快1名、80%回
復1名となり、効果率は80%であった。
(Example 2) 5 g of germanium powder containing 0.2% of aluminum was thoroughly kneaded with 20 g of Sophina Moisture Pack N made by Kao, and 4 patients with moderate low back pain and 2 patients with severe low back pain Kyoyama, Renyu, Shimuro, It was applied to large intestine and Sekimoto. Application was done every morning and after bathing. After 7 days, there were 3 patients with moderate disease, 1 patient without improvement, 1 patient with severe disease, 1 patient with 80% recovery, and the efficacy rate was 80%.

【0013】(実施例3)硼素0.4%添加シリコン粉
末10gと酸化チタン10gとを資生堂製エリクシール
・トリートメント・マスク110gで良く練り、30代
男性3名、女性4名、40代男性5名、女性3名の被験
者に対し、目尻、額、頬などの皺に毎夜入浴後つけさ
せ、翌朝取らせた。2週間後著効有り6名、効果あり4
名、効果無し2名、不明3名の結果となり、効果率は7
5%であった。比較のため、燐400ppm 添加シリコン
粉末2gと酸化チタン2gとを資生堂製エリクシール・
トリートメント・マスク10gで良く練り、30代男性
2名、40代男性3名の被験者に対し、同条件で試験し
たところ、1日で1名が違和感を訴えたので試験は中止
した。
(Example 3) 10 g of silicon powder with 0.4% boron added and 10 g of titanium oxide were thoroughly kneaded with 110 g of Elixir Treatment Mask manufactured by Shiseido, and 3 men in their 30s, 4 women in their 40s and 5 men in their 40s , Three female subjects were allowed to apply wrinkles on the corners of the eyes, forehead, cheeks, etc. after bathing every night and then take them the next morning. After 2 weeks, 6 responded and 4 treated
Results, 2 with no effect, 3 with no effect, effect rate 7
It was 5%. For comparison, 2 g of 400 ppm phosphorus-added silicon powder and 2 g of titanium oxide were made by Shiseido Elixir.
The treatment mask was thoroughly kneaded with 10 g, and when tested in the same conditions on 2 subjects in their 30s and 3 subjects in their 40s, one subject complained of discomfort in one day, so the test was discontinued.

【0014】(実施例4)硼素180ppm 添加シリコン
粉末2gを花王製ソフィーナモイスチュアパック10g
で良く練り、腕の腱鞘炎患者8名の手三里、陽池、曲
池、尺沢の各経絡に先ず塗り、10分後半乾燥の状態
で、硼素180ppm 添加シリコン粉末2gと酸化チタン
2gとを花王製ソフィーナモイスチュアパック20gで
良く練った液、及び赤色酸化鉄2gを花王製ソフィーナ
モイスチュアパック10gで良く練った液を適宜混ぜな
がら各自の皮膚に合わせてその上に塗り、乾燥させた。
乾燥後、パック剤は安静状態なら取れないが運動すると
とれるので、半透明の絆創膏で止めておいた。3日後全
快3名、1週間後全快2名、80%改善1名、やや改善
1名、無効1名となり、効果率は75%であった。
(Example 4) 2g of silicon powder with 180ppm of boron was added to 10g of Sophina Moisture Pack manufactured by Kao Corporation.
Well, apply it to the meridians of Tezuri, Yoike, Kugaike and Shakusawa of eight patients with tenosynovitis of the arm first, and in the dry state for the latter half of 10 minutes, 2g of silicon powder containing 180ppm of boron and 2g of titanium oxide were applied to Kao. A solution well kneaded with 20 g of Sofina Moisture Pack made by Sofina and a solution well kneaded with 10 g of Sofina Moisture Pack made by Kao of 2 g of red iron oxide were appropriately mixed and applied on the skin, and dried.
After drying, the pack cannot be removed if it is in a resting state, but since it can be taken with exercise, it was stopped with a semitransparent bandage. 3 days later, 3 weeks later, 2 weeks later, 1 person improved 80%, 1 person improved slightly, 1 person disabled, and the effect rate was 75%.

【0015】(実施例5)硼素480ppm 添加シリコン
粉末30gを柳屋ヘアトニック300gに入れてよく攪
拌したものを、白髪3名、薄毛2名の被験者に週3回洗
髪後つけさせた。5ケ月後白髪1名、薄毛1名には効果
が認められた。また、白髪1名もやや効果ありと判断さ
れた。
Example 5 30 g of silicon powder containing 480 ppm of boron was placed in 300 g of Yanagiya Hair Tonic, and the mixture was thoroughly stirred. Then, three gray hair subjects and two thin hair subjects were washed three times a week with hair. After 5 months, the effect was recognized in 1 gray hair and 1 thin hair. One gray hair was also judged to be slightly effective.

【0016】(実施例6)亜鉛280ppm 添加ガリウム
燐粉末30を導電性エポキシ樹脂に混合し、直径6mm、
厚さ6mmのアルミナペレット表面に塗布し、このペレッ
トをプラスターで肩凝り患者5名の肩井、巨骨、曲垣、
天宗、中府、の各経絡に貼り、治験を行った。3日貼り
1日休んで更に3日貼り、7日後完治2名、80%回復
1名、50%回復1名、変わらず1名という結果が得ら
れ、効果率は約70%であった。
(Embodiment 6) 280 ppm zinc-added gallium phosphide powder 30 was mixed with a conductive epoxy resin, and the diameter was 6 mm.
It was applied to the surface of alumina pellets with a thickness of 6 mm, and the pellets were plastered, and the shoulders of 5 patients with stiff shoulders, large bones, curved walls,
I attached it to each meridian of Tenmune and Chufu and conducted a clinical trial. Sticking for 3 days, resting for 1 day, sticking for 3 days, and after 7 days, 2 patients were completely healed, 1 patient was 80% recovered, 1 patient was 50% recovered, and 1 patient remained unchanged. The effect rate was about 70%.

【0017】(実施例7)直径6mm、高さ1.5mmの円
柱上に更に高さ1mmの円錐を設けた酸化チタンを用いた
セラミックス成形体に、硼素200ppmドープp形シ
リコンを使用して、スパッタリング法により厚さ10オ
ングストロームの薄膜を形成した。この半導体治療剤を
直径20mmのプラスターで腰痛、肩凝り、頭痛、歯痛患
者に貼付し治験を行った。比較例として、上記セラミッ
クス成形体に、燐200ppmドープn形シリコンを使
用して、スパッタリング法により厚さ10オングストロ
ームの薄膜を形成したものを準備し、二重盲検法で比較
試験した。結果は表1の通りである。
(Embodiment 7) A 200 ppm boron-doped p-type silicon is used in a ceramic body made of titanium oxide in which a circular cone having a diameter of 6 mm and a height of 1.5 mm is further provided with a cone having a height of 1 mm. A thin film having a thickness of 10 angstrom was formed by the sputtering method. This semiconductor therapeutic agent was applied to patients with low back pain, stiff shoulders, headache, and toothache with a plaster with a diameter of 20 mm, and a clinical trial was conducted. As a comparative example, a 200-ppm phosphorus-doped n-type silicon was used to form a thin film having a thickness of 10 angstroms by a sputtering method on the above-mentioned ceramic molded body, and a comparative test was conducted by a double-blind method. The results are shown in Table 1.

【0018】[0018]

【表1】 [Table 1]

【0019】表1に示すように、本実施例によれば、有
効率は平均79%、悪化率0%であったが、比較例で
は、有効率は平均48%、悪化率10%となっている。
悪化は主に貼付した場所の痛みが増加する例が多かった
が、1例は全く別の部位の痛みが発生したのですぐ除去
したところ痛みは消滅した。
As shown in Table 1, according to this example, the effective rate was 79% on average and the deterioration rate was 0%, but in the comparative example, the effective rate was 48% on average and the deterioration rate was 10%. ing.
As for the exacerbation, there were many cases in which pain was increased mainly at the place where it was applied, but in one case, pain occurred at a completely different site, so the pain disappeared immediately after removal.

【0020】[0020]

【発明の効果】以上説明したように、本発明の半導体治
療剤は、p形半導体を使用するため効果が良く、副作用
もない。また、薄膜状、粉末状ともに使用できるので、
筋肉痛、肩こり等の治療に加え、皺とり、育毛などにも
有効である。また、粉体状使用する場合は、皮膚の色に
合わせて調色することにより目立たない状態で使用でき
る。
As described above, since the semiconductor therapeutic agent of the present invention uses the p-type semiconductor, it is effective and has no side effect. Also, since it can be used in both thin film and powder form,
In addition to treating muscle soreness and stiff shoulders, it is also effective for wrinkling and hair growth. When used in powder form, it can be used in an inconspicuous state by adjusting the color to match the color of the skin.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 人体の皮膚表面に接触可能なp形半導体
からなる半導体治療剤。
1. A semiconductor therapeutic agent comprising a p-type semiconductor capable of contacting the skin surface of a human body.
【請求項2】 p形半導体がシリコン半導体薄膜、ゲル
マニウム半導体薄膜、ガリウム燐半導体薄膜、硫化亜鉛
半導体薄膜、又はシリコン半導体粉末、ゲルマニウム半
導体粉末、ガリウム燐半導体粉末、硫化亜鉛半導体粉
末、もしくはその混合物である請求項1記載の半導体治
療剤。
2. The p-type semiconductor is a silicon semiconductor thin film, a germanium semiconductor thin film, a gallium phosphorus semiconductor thin film, a zinc sulfide semiconductor thin film, or a silicon semiconductor powder, a germanium semiconductor powder, a gallium phosphorus semiconductor powder, a zinc sulfide semiconductor powder, or a mixture thereof. The semiconductor therapeutic agent according to claim 1.
【請求項3】 粉末状のp形半導体に顔料を加えて調色
した請求項1または請求項2記載の半導体治療剤。
3. The semiconductor therapeutic agent according to claim 1 or 2, which is prepared by adding a pigment to powdered p-type semiconductor to prepare a color.
【請求項4】 粉末状のp形半導体がクリーム、パッ
ク、又は育毛剤と混合されている請求項1、請求項2、
または請求項3記載の半導体治療剤。
4. The powdery p-type semiconductor is mixed with a cream, a pack, or a hair restorer, and claim 1,
Alternatively, the semiconductor therapeutic agent according to claim 3.
【請求項5】 粉末状のp形半導体が皮膚に貼着可能な
媒体に付着されている請求項1、請求項2、または請求
項3記載の半導体治療剤。
5. The semiconductor therapeutic agent according to claim 1, 2 or 3, wherein the powdery p-type semiconductor is attached to a medium that can be attached to the skin.
【請求項6】 p形半導体がセラミックス、プラスチッ
ク、ガラス、又は金属の成形体表面に形成された半導体
薄膜である請求項1、または請求項2記載の半導体治療
剤。
6. The semiconductor therapeutic agent according to claim 1, wherein the p-type semiconductor is a semiconductor thin film formed on the surface of a molded body of ceramics, plastic, glass, or metal.
JP5038851A 1992-04-07 1993-02-26 Semiconductor therapeutics Expired - Fee Related JP2572520B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5038851A JP2572520B2 (en) 1992-04-07 1993-02-26 Semiconductor therapeutics

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8556492 1992-04-07
JP4-85564 1992-04-07
JP5038851A JP2572520B2 (en) 1992-04-07 1993-02-26 Semiconductor therapeutics

Publications (2)

Publication Number Publication Date
JPH05337192A true JPH05337192A (en) 1993-12-21
JP2572520B2 JP2572520B2 (en) 1997-01-16

Family

ID=26378142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5038851A Expired - Fee Related JP2572520B2 (en) 1992-04-07 1993-02-26 Semiconductor therapeutics

Country Status (1)

Country Link
JP (1) JP2572520B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607453A (en) * 1994-04-28 1997-03-04 Furukawa Co., Ltd. Composite medical treating device composed ferrodielectric substance and semiconductor
US8079346B2 (en) 2005-06-28 2011-12-20 Yasuo Sakakura Oxygen activating material, combustion efficiency improving material, plant growth promoting material, aerobic microorganism activating material, animal growth promoting and activating material, muscle softening material, rust removing and preventing material, and oxygen activating method
JP2015195939A (en) * 2014-04-01 2015-11-09 株式会社イノベイト Paste treatment tool

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS581465A (en) * 1981-06-25 1983-01-06 浜田 亨 Skin contact piece for health

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS581465A (en) * 1981-06-25 1983-01-06 浜田 亨 Skin contact piece for health

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607453A (en) * 1994-04-28 1997-03-04 Furukawa Co., Ltd. Composite medical treating device composed ferrodielectric substance and semiconductor
US8079346B2 (en) 2005-06-28 2011-12-20 Yasuo Sakakura Oxygen activating material, combustion efficiency improving material, plant growth promoting material, aerobic microorganism activating material, animal growth promoting and activating material, muscle softening material, rust removing and preventing material, and oxygen activating method
JP2015195939A (en) * 2014-04-01 2015-11-09 株式会社イノベイト Paste treatment tool

Also Published As

Publication number Publication date
JP2572520B2 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
Scholes et al. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate.
US4317457A (en) Electroconducting cast forming a cutaneous electrode for applying electrical currents to the human body for therapeutic or aesthetic treatment and method of using such electroconducting cast
JPH10513452A (en) Formulations and methods for reducing skin irritation
JPH1067672A (en) Treatment of various resistant infection, cancer, other disease which has infection in case in which metal is deposited in pathological area
US5571794A (en) Non-invasive novel method fo cosmetic lip augmentation
AlGhamdi et al. Skin care: historical and contemporary views
ALBRIGHT et al. Rapid treatment of tinea versicolor with selenium sulfide
JPH05337192A (en) Semiconductor curing agent
JPH09278624A (en) Cosmetic
Spiegel et al. AEC syndrome: Ankyloblepharon, ectodermal defects, and cleft lip and palate: Report of two cases
JPS61260010A (en) Hair growing agent
JPH10245345A (en) Agent for preventing dermatitis
Lewis et al. CONTACT DERMATITIS FROM CHLORPROMAZINE: REPORT OF TWO CASES
JPH05310597A (en) Agent for contact treatment
KR100809488B1 (en) sheet-type hydrogel pack
JPS6316345Y2 (en)
Emmett et al. Allergic contact dermatitis from TEA-Coco hydrolyzed protein
Berger et al. Failure of topical testosterone in male-pattern alopecia
McNALLY et al. Thioglycollate Cold Wave Process
JPH08154967A (en) Cover material for treating dermatophytosis
RU93053628A (en) ACTIVE INGREDIENT, METHOD FOR ITS PREPARATION, COMPOSITION ON ITS BASIS, METHOD FOR PREPARING IT
JP2001010923A (en) Composition having germicidal action, cosmetic comprising the same composition and ultraviolet light blocking material
RU2242964C1 (en) Cosmetic agent for stimulating hair growth
Nahlieli et al. Cutaneous horns occurring on the head and neck region: report of four cases and review of the literature
CN110522668A (en) A kind of micro-current antibacterial facial mask and preparation method thereof

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19960813

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081024

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081024

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091024

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091024

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101024

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111024

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111024

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121024

Year of fee payment: 16

LAPS Cancellation because of no payment of annual fees